CPDR: An R Package of Recommending Personalized Drugs for Cancer Patients by Reversing the Individual's Disease-Related Signature

• Autors principals: Ruzhen Chen (Autor), Xun Wang (Autor), Xinru Deng (Autor), Lanhui Chen (Autor), Zhongyang Liu (Autor), Dong Li (Autor)
• Format: Llibre
• Publicat: Frontiers Media S.A., 2022-06-01T00:00:00Z.
• Matèries: article
• Accés en línia: Connect to this object online.

Due to cancer heterogeneity, only some patients can benefit from drug therapy. The personalized drug usage is important for improving the treatment response rate of cancer patients. The value of the transcriptome of patients has been recently demonstrated in guiding personalized drug use, and the Co...